Probiotics to increase IgA secretion in infants born by Caesarean section
US9060540B2 · kind B2 · utility
6Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2009 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | May 6, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for increasing IgA secretion in an infant delivered by cesarean section during the first four months of the life of the infant.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.